Beneficial effects of carvedilol on cardiomyocyte apoptosis and bcl-2/bax expression after acute myocardial infarction an experiment with rats

National Medical Journal of China

Volumn 86, Issue 13, 2006, Pages 919-922

  Yang, Yue Jin ^a   Chen, Yue Feng ^a   Ruan, Ying Mao ^a   Chen, Xi ^a   Zhang, Hui Dong ^a   Tian, Yi ^a   Zhou, Yan Wen ^a   Wang, Qing Zhi ^a   Si, Wen Xue ^a   Chen, Ji Lin ^a   Gao, Run Lin ^a   Chen, Zai Jia ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

adrenergic receptor antagonist; Apoptosis; Myocardial infarction; Oncogenes; Rats

Indexed keywords

CARVEDILOL; DNA; PROTEIN BAX; PROTEIN BCL 2; SODIUM CHLORIDE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DNA DETERMINATION; DRUG DOSE REGIMEN; FEMALE; GEL ELECTROPHORESIS; GENE EXPRESSION; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LONG TERM CARE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SCAR; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CARBAZOLES; FEMALE; IMMUNOHISTOCHEMISTRY; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROPANOLAMINES; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33646023369     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 1996,74:86-107.
2. Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res, 1996,226:316-327.
3. Li Q, Li B, Wang X, et al. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest, 1997,100:1991-1999.
4. Yang YJ, Tang YD, Ruan YM, et al. Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats. Circ J, 2003,67:159-162.
5. Weisman HF, Mannisi JA, Weisfeldt ML, et al. Cellular mechanisms of myocardial infarct expansion. Circulation, 1988,78: 186-201.
6. Yang YJ, Zhang P, Ruan YM, et al. Comparison of the effects of losartan, enalapril and their combination in the prevention of left ventricular remodeling after acute myocardial infarction in the rat. Chin Med Sci J, 2002, 17: 236-241.
7. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res, 1985,57: 84-95.
8. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med, 1997,336:1131-1141.
9. Sam F, Sawyer DB, Chang DL, et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol, 2000,279:H422-428.
10. Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest, 1997, 100: 1363-1372.
11. Doughty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 2004,109:201-206.
12. Yuc TL, Ma XL, Wang X, et al. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of irchemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res, 1998,82:166-174.